Search the Newsreel

Confidence Intelligence warns of interim loss on margin squeeze and rising component costs

Intelligent Bio Solutions' Fingerprint Drug Study Enrolled 135

Intelligent Bio Solutions (Nasdaq: INBS) has completed its multi-site Method Comparison Study for the Intelligent Fingerprinting Drug Screening System, enrolling 135 participants across three U.S. sites. This marks the completion of all clinical data collection for its FDA 510(k) submission to detect codeine. The …

Adtiger Board to Review Interim Results and Consider Dividend

Renaissance Technologies LLC Has $2.17 Million Stake in Prestige Consumer Healthcare Inc. $PBH

Renaissance Technologies LLC significantly reduced its stake in Prestige Consumer Healthcare Inc. (PBH) by 62% in the first quarter, selling 59,900 shares but retaining 36,702 shares valued at approximately $2.17 million. Despite this, institutional investors collectively own 99.95% of PBH. Prestige Consumer Healthcare reported …

Quantinno Capital Management LP Acquires 19,281 Shares of Prestige Consumer Healthcare Inc. $PBH

Quantinno Capital Management LP significantly increased its stake in Prestige Consumer Healthcare Inc. (PBH) by acquiring 19,281 shares, bringing its total holdings to 36,990 shares valued at $2.19 million. Institutional investors collectively own 99.95% of PBH. The company also surpassed quarterly earnings expectations, reporting …

Intelligent Bio Solutions Completes Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions has completed a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System, a crucial step for its FDA 510(k) submission to detect codeine in the U.S. market. The study involved 135 participants across three clinical sites and evaluated the …

Rigetti Computing, Inc. $RGTI Shares Sold by First Trust Advisors LP

Intelligent Protection Management Corp (IPM) Earnings Forecast: Future EPS & Revenue Growth Estimates

Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Prestige Consumer Healthcare (PBH) Is Up 5.6% After Raising Fiscal 2027 Outlook on Acquisitions

Prestige Consumer Healthcare (PBH) saw its stock rise by 5.6% after reporting its fiscal 2027 first-quarter results and subsequently raising its full-year outlook. The company's updated revenue guidance of US$1.29 billion–US$1.32 billion and GAAP diluted EPS guidance of US$4.18–US$4.28 are primarily driven by recent …

Repligen Corporation (NASDAQ:RGEN) Given Average Rating of "Moderate Buy" by Brokerages

Repligen Corporation (NASDAQ:RGEN) has received a "Moderate Buy" consensus rating from eighteen brokerages, with an average 12-month price target of $166.43. The company recently surpassed quarterly earnings and revenue expectations, reporting $0.54 EPS and $204.13 million in revenue, an 11.9% year-over-year increase. Despite a …

Intelligent Monitoring Group (ASX:IMB): Security Roll-Up Strategy Moves Towards Profitability

VGNTw Price Today: Versigent PLC Stock Price, Quote & Chart | MEXC

This article provides the stock price, key market data, and company information for Versigent PLC (VGNTw), which designs and manufactures electrical architecture systems for vehicles and other industries. It details how to buy VGNTw on MEXC, its industry classification, and answers frequently asked questions …

Prestige Consumer Executives Set for Aug. 12 Fireside Chat

Prestige Consumer Healthcare Inc. (NYSE: PBH) announced that its CFO and COO, Christine Sacco, and VP of Investor Relations, Treasury, & Business Development, Phil Terpolilli, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, at …

Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference

Prestige Consumer Healthcare Inc. announced that its CFO and COO, Christine Sacco, and VP of Investor Relations, Treasury, & Business Development, Phil Terpolilli, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference. The event is scheduled for Wednesday, August …

Repligen Shares Surge 16.2% as Record Revenue Offsets Shrinking Q2 Margins

Why CCC Intelligent Solutions (CCC) Is Up 13.6% After Strong Q2 Results, Guidance And Buyback Completion

CCC Intelligent Solutions Holdings Inc. (CCC) saw its stock rise by 13.6% following strong second-quarter 2026 results, positive guidance for Q3 and the full year, and the completion of a significant share buyback program. The company's increased profitability and confident outlook reinforce its investment …

BOCOM International: BeiGene maintains 'Buy' rating with target price raised to HK$276

BOCOM International has maintained its 'Buy' rating for BeiGene, increasing the target price to HK$276. This reflects a positive outlook on the biopharmaceutical company's future performance and valuation.

This Is When IBM's CEO Says Quantum Computing Could Start to Have a "Measurable Impact" on Its Bottom Line

Quantum computing has been an area of tech that growth investors have been targeting in recent years. In 2024, shares of Rigetti Computing soared more than 1,400%. While the enthusiasm has cooled of late given the long-term question marks and uncertainty around the business, …

Rigetti Computing Shares Plunge Amid Investor Skepticism

Rigetti Computing's shares plunged 22.6% last month due to investor skepticism regarding unprofitable companies in the AI and quantum computing sectors, driven by high R&D costs and an operating loss of $54 million against low revenue. Despite having a strong cash position of $541.3 …

Why Rigetti Stock Fell 22% in July

Shares of Rigetti Computing (NASDAQ: RGTI) fell 22.6% last month, according to data provided by S&P Global Market Intelligence, as investors grew impatient with unprofitable companies. Investors rotated out of many AI stocks as skepticism spread that all the money being spent in the …

Rigetti Computing Stock Surged -- Here Is What Is Driving the Rally

Key Points Rigetti is receiving major government backing to reinforce its position as a strategic quantum computing player. Still, it remains an early-stage company with significant losses, making it a high-risk, high-reward investment.10 stocks we like better than Rigetti Computing › Rigetti Computing (NASDAQ: …

Rigetti Computing, Inc. (NASDAQ:RGTI) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Rigetti Computing, Inc. (NASDAQ:RGTI) recently released its second-quarter results, showing revenues in line with expectations at US$5.1m, but statutory losses per share increased to US$0.16. Analysts have updated their forecasts for 2026, predicting revenues of US$23.3m (a 74% increase) but a significant increase in …

Rigetti Computing, Inc. (NASDAQ:RGTI) acaba de publicar sus resultados del segundo trimestre y los analistas están actualizando sus previsiones

Soligenix culls topical lymphoma asset after Phase III miss

Soligenix has ended the development of its topical cutaneous T-cell lymphoma (CTCL) therapy, HyBryte, after the drug failed to meet its primary goals in a Phase III trial. The company will now focus on its pipeline candidate, dusquetide, for Behçet's disease and developing commercial …

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Standout with 13.3% Potential Upside

Repligen Corporation (RGEN) is analyzed as a strong player in the healthcare sector, specifically medical instruments and supplies, with a current market cap of $9.25 billion and a potential upside of 13.3% according to analysts. The company shows promising revenue growth, positive analyst sentiment …

Zhong An Intelligent Living Service Sets August Board Meeting for Interim Results and Dividend Review

Rigel Pharmaceuticals, Inc. $RIGL Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Rigel Pharmaceuticals (NASDAQ:RIGL) by 37.1% in the first quarter, now owning 379,541 shares valued at $10.3 million. This contributed to institutional investors holding 66.23% of the stock. Despite a "Strong Sell" downgrade from Zacks Research, …

Repligen (RGEN) Is Up 16.2% After Revenue Rises But Profitability Compresses In Q2 2026

In July 2026, Repligen Corporation reported second-quarter 2026 results showing revenue of US$204.13 million versus US$182.37 million a year earlier, while net income fell to US$5.01 million from US$14.87 million and diluted EPS from continuing operations decreased to US$0.09 from US$0.26. Over the six-month …

Soligenix (SNGX) Receives a Buy from Alliance Global Partners

Alliance Global Partners analyst James Molloy maintained a Buy rating on Soligenix (SNGX) with a price target of $1.50. Despite Molloy's historical average return, the analyst consensus on Soligenix is a Moderate Buy with an average price target of $1.50. The company recently reported …

Repligen (RGEN) Could Be 10% Below Fair Value On Mixed Q2 Earnings

Repligen (RGEN) recently reported mixed Q2 2026 earnings, showing higher revenue but lower net income and EPS year-over-year. Despite this, the stock has seen strong recent momentum, with a 90-day return of 41.4% and a 1-year return of 47.09%, positioning it about 10% below …

Rigetti Computing Stock (RGTI) Opinions on Recent Earnings Release

Versigent Q2 Earnings Call Highlights

Key Points Interested in Versigent? Here are five stocks we like better. Strong second-quarter performance: Net sales rose 11% year over year to $2.4 billion, while adjusted EBITDA increased 25% to $272 million and margins expanded to 11.1%. Versigent also secured more than $2.8 …

Precigen (PGEN) Could Be 50% Undervalued On Strong Earnings Turnaround

Prestige Consumer Healthcare (PBH) Following Its 2027 Outlook Raise And The Undervalued View

Prestige Consumer Healthcare (PBH) has raised its fiscal 2027 revenue and earnings outlook, projecting revenue between $1.29b and $1.32b and GAAP diluted EPS between $4.18 and $4.28, driven by the integration of two recent acquisitions. Despite a mixed share price performance over the past …

This Trillion-Dollar AI Stock Offers Better Quantum Computing Exposure Than IonQ, Rigetti, or D-Wave at a Multi-Year Valuation Low

Key Points Microsoft gives you quantum exposure without needing quantum to succeed tomorrow. For long-term investors, Microsoft offers a more balanced risk-reward profile than pure-play quantum companies. If quantum adoption takes longer than expected, you still own one of the world's leading AI and …